Hospital
Prime Healthcare Services Blue Springs, LLC
Prime Healthcare Services Blue Springs, LLC was paid $10.51M by Medicaid between Jan 2018 and Dec 2024, across 49 billing codes. Its largest line is 99283, emergency room visit (moderate) — 18% of everything it billed.
33Billing provider infoPRIME HEALTHCARE SERVICES BLUE SPRINGS, LLC
BLUE SPRINGS, MO 64014
BLUE SPRINGS, MO 64014
33aNPI1912303579assigned 11/10/2014
33bProvider typeGeneral Acute Care Hospital
28Total paid$10.51M
24GClaims82,074
24DCodes billed49
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Missouri
Rank by total paid#26 of 74
Median peer was paid$4.44M
This provider vs. median2.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official DOAN, CHRISTOPHER controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,918 | $2.47M | |
| 2019 | 6,584 | $2.36M | |
| 2020 | 9,765 | $1.92M | |
| 2021 | 10,142 | $266K | |
| 2022 | 16,963 | $1.03M | |
| 2023 | 24,060 | $1.64M | |
| 2024incomplete | 8,642 | $816K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 18% | 12,210 | 11,280 | $1.86M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 17% | 6,210 | 5,694 | $1.76M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 14% | 4,880 | 4,233 | $1.49M |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 10% | 9,779 | 8,327 | $1.06M |
| 80053 | Comprehensive metabolic panel | 9.3% | 8,615 | 7,296 | $978K |
| X4014 | 7.1% | 2,240 | 1,759 | $748K | |
| X4011 | State-specific procedure code | 5.8% | 1,618 | 1,378 | $611K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 5.0% | 3,554 | 1,651 | $521K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.9% | 3,230 | 2,641 | $198K |
| 71045 | Radiologic examination, chest; single view | 1.8% | 2,525 | 2,141 | $190K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.4% | 1,624 | 1,419 | $145K |
| 81025 | 1.3% | 2,040 | 1,843 | $142K |
37 more codes
| 83690 | 1.0% | 2,351 | $106K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,201 | $95K |
| 81001 | <1% | 1,846 | $77K | |
| 81003 | <1% | 1,345 | $76K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 352 | $72K |
| 87081 | <1% | 158 | $54K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,921 | $53K |
| 84484 | <1% | 1,592 | $44K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 887 | $37K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 2,817 | $34K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 728 | $26K |
| 80305 | <1% | 340 | $22K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 159 | $17K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,551 | $17K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 282 | $13K |
| 82550 | <1% | 135 | $10K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 295 | $9K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 186 | $7K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 29 | $6K |
| X4003 | <1% | 30 | $6K | |
| 85730 | <1% | 44 | $3K | |
| 85610 | <1% | 48 | $3K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 544 | $3K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 56 | $2K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 14 | $2K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 95 | $2K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 27 | $2K |
| 83735 | <1% | 140 | $471.35 | |
| 83880 | <1% | 16 | $325.76 | |
| 83605 | <1% | 58 | $306.41 | |
| 87807 | <1% | 28 | $229.95 | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 17 | $185.47 |
| 85027 | <1% | 82 | $149.47 | |
| 87077 | <1% | 16 | $115.72 | |
| 80076 | <1% | 17 | $90.47 | |
| 86140 | <1% | 23 | $34.21 | |
| J3490 | Unclassified drugs | 0% | 1,119 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDOAN, CHRISTOPHER (MANAGING ASSOCIATE GENERAL COUNSEL)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.